Top Health-care stocks:
Health-care shares were mainly inactive in pre-market trade Thursday.
In health-care stocks news, Navidea Biopharmaceuticals ( NAVB ) said a clinical imaging study showed Karposi's Sarcoma tumor lesions can be visualized and mapped with its Tc 99m tilmanocept, a Manocept platform product.
Shares in the company were trading 6.8% higher at $1.73 during pre-market trading . Over the past 52 weeks, the company has traded between $0.97 and $2.02.
Meanwhile, AmSurg ( AMSG ), a surgery center operator and outsourced physician provider, said its Sheridan unit has acquired Coastal Anesthesiology Consultants, a provider of anesthesia services for Flagler Hospital facilities in the St. Augustine, Florida, market. Financial terms of the deal were not disclosed.
Shares in the company were unchanged at $70.20 during pre-market trading. Over the past 52 weeks, the company has traded between $45.19 and $72.85.
And AcelRx Pharmaceuticals ( ACRX ) said it has published the results of a phase 3 study of its Zalviso drug in Anesthesiology, showing it met the primary endpoint of significantly reducing post operative pain over 48 hours.
Shares in the company were 9.5% higher at $4.50 during pre-market trading. Over the past 52 weeks, the company has traded between $2.96 and $11.65.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.